Initial Results from a Phase 1/2 Dose Escalation and Expansion Study Evaluating MS-553, a Novel and Selective PKCβ Inhibitor, in Patients with CLL/SLL
| Autor: | Blachly, James S., Stephens, Deborah M., Ye, J Christine, Lamanna, Nicole, Jain, Nitin, Niesman, Michael *, Zhang, Kai *, Woyach, Jennifer A. |
|---|---|
| Zdroj: | In Blood 15 November 2022 140 Supplement 1:2324-2325 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|